Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Puja Nistala"'
Autor:
Chen Wang, Ravi Nistala, Min Cao, Yi Pan, Madelaine Behrens, Donald Doll, Richard D. Hammer, Puja Nistala, Hui-Ming Chang, Edward T.H. Yeh, XunLei Kang
Publikováno v:
Cell Reports, Vol 42, Iss 2, Pp 112105- (2023)
Summary: Leukemic-stem-cell-specific targeting may improve the survival of patients with acute myeloid leukemia (AML) by avoiding the ablative effects of standard regimens on normal hematopoiesis. Herein, we perform an unbiased screening of compounds
Externí odkaz:
https://doaj.org/article/4fd2c19656ae473ea08c0f7aeb939853
Autor:
Chen Wang, Ravi Nistala, Min Cao, Madelaine Behrens, Donald Doll, Richard D. Hammer, Puja Nistala, Hui-Ming Chang, Edward T.H. Yeh, XunLei Kang
Publikováno v:
SSRN Electronic Journal.
Autor:
Michael X. Wang, James Shortridge, Dong Xiang, Shahzad Raza, Brandon M. Huffman, Puja Nistala, Hariharan Regunath
Publikováno v:
Oncology Letters
Catastrophic antiphospholipid antibody syndrome (CAPS) is characterized by fulminant thrombosis of the arterial and venous beds of multiple organ systems over a relatively short period of time and with a high mortality rate. Mucosa-associated lymphoi
Publikováno v:
Current Hypertension Reviews. 5:210-221
Type 2 Diabetes Mellitus (T2DM) and hypertension (HTN) both increase cardiovascular disease (CVD) morbidity and mortality, and impose a tremendous burden on worldwide heath care systems in recent years. The mechanisms underlying the frequent coexiste
Autor:
Puja Nistala, Murali Kodali, James Shortridge, Donald C. Doll, Gautam Kishore Kale, Shahzad Raza
Publikováno v:
British Journal of Haematology. 167:1-1
Publikováno v:
Blood. 122:5071-5071
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma, accounting for about 1/3rd cases of NHL. At diagnosis, DLBCL involves the bone marrow in approximately 15-25% of cases. However, the bone marrow may reveal discordant morp
Publikováno v:
Blood. 120:4967-4967
4967 Background: Multiple myeloma (MM) is a common hematological malignancy affecting all races and the incidence is increasing. The rise in incidence is partly due to an increase in average life span in the patient population above the age of 65. It